Insights

Why Big Pharma Hasn’t Fully Adopted 3D Printing—Yet: Inside Triastek’s Push to Modernize Drug Manufacturing

Why Big Pharma Hasn’t Fully Adopted 3D Printing—Yet: Inside Triastek’s Push to Modernize Drug Manufacturing

December 5, 2025 Medical

In pharmaceutical manufacturing, tablets have long been produced through standardized processes that leave little room for fine-tuning how a drug behaves once ingested. Chinese pharmaceutical technology company Triastek is challenging that model. By applying 3D printing to drug product development and manufacturing, the company is introducing a more controlled and predictable way to engineer oral medications.

Read More

News

We realize your creation

FacFox provides one-stop solution with comprehensive on-demand manufacturing capabilities and data-driven analysing technologies, see our available service, feel free to reach us to realize your creation!

Most Viewed

Competition Heats Up Over Volumetric Printing Patents Legislation

Competition Heats Up Over Volumetric Printing Patents Legislation

Volumetric printing, as this network reported, has arrived in the form of the xolo xube, but this revolutionary technology already faces contenders for volumetric printing patents. A United States patent filed by Mr. Daniel Clark of Topshelf Enterprises (T3DP) and Southern Methodist University claims technology similar to xolo’s volumetric process. Mr. Clark points to his patent as occupying the field in which xolo has released a product.

93506d675eec06add60ef8d81cabb105.jpg

Stratasys Extreme Redesign 3D Printing Challenge Winners Unveiled AM Software

Stratasys Ltd. the 3D printing and additive manufacturing solutions company, unveiled the winning entries for the 2017 Extreme Redesign 3D Printing Challenge. Judging submissions from more than 900 student inventors, engineers, artists, and entrepreneurs, this year’s contest was co-hosted by GrabCAD and fully supported in the GrabCAD Community – the world’s largest online collaborative environment for designers, engineers, and manufacturers.